Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in cipla

Cipla Betting High On Digitisation, Emerging Segments

Over the past few years, the company has set up several foundational elements to drive the digitisation and automation plans right from adopting latest trends to transform patient reach and customer care via digitalisation, Hamied stated

Read More

Cipla Reports Decline In Net Profit To Rs 706 Cr In Q1 Results

The Mumbai-based company had reported a net profit of Rs 710 crore in the April-June quarter of the last fiscal

Read More

Cipla To Aquire Additional Stake Worth Rs 26 Cr In GoApptiv

Cipla's earlier investment in GoApptiv in June 2020 has yielded growth and expanded Cipla's channel

Read More

Cipla To Acquire 21% Stake In Diagnostic Company Achira Labs For Rs 25 Cr

The company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filing

Read More

Cipla's Sales Increase 14% To Rs 52 Bn In Q4FY22

EBITDA came in at Rs 9.5 billion while PAT adjusted at Rs 5.9 billion

Read More

Cipla To Acquire 32.49% Stake In Solar Power Firm Amp Energy

The acquisition is in line with the commitment to enhance the share of renewable power sources in its operation and to comply with regulatory requirements for being a captive user under Indian electricity laws

Read More

InvaGen To Continue To Hold Shares In Avenue Therapeutics: Cipla

Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million.

Read More

Cipla Unit Gets Notice From US Firm For Termination Of Acquisition Deal

Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million

Read More

Eli Lilly To Transfer Rights Of Two Diabetes Products To Cipla

The Gurgaon-based firm, which is a wholly-owned subsidiary of US-based Eli Lilly and Company, has inked a pact with Cipla in this regard.

Read More

Cipla, Kemwell Form JV For Developing, Commercialising Biosimilars

'This development reinforces our strength as leaders in respiratory therapy and is in line with our aspiration of global lung leadership,' Cipla Managing Director and Global Chief Executive Officer (CEO) Umang Vohra said.

Read More

Cipla Gets USFDA Nod For Inhalation Product

Brovana is used in maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Read More

Avenue Therapeutics Gets Second Complete Response Letter From USFDA For Intravenous Tramadol

The CRL stated that the delayed and unpredictable onset of analgesia with intravenous tramadol does not support its benefit as a monotherapy to treat patients in acute pain

Read More

Seeking Clarity, Guidance From Govt For Vaccine Import: Cipla

Shares of Cipla closed at Rs 946.40 per scrip on BSE, down 0.29 per cent from its previous close.

Read More

Cipla Launches RT-PCR Test Kit 'Viragen' In India Partnership With Ubio Biotech

Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems

Read More

Cipla Q4 Profit Up 73 % At Rs 412 Cr

Total revenue from operations rose to Rs 4,606 crore as compared with Rs 4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing.

Read More